Breast Cancer Research and Treatment

, Volume 105, Issue 1, pp 81–85

Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature

  • Alberto Luini
  • Giovanna Gatti
  • Jack Diaz
  • Edoardo Botteri
  • Eliegina Oliveira
  • Rafaela Cecilio Sahium de Almeida
  • Paolo Veronesi
  • Mattia Intra
  • Gianmatteo Pagani
  • Paola Naninato
  • Giuseppe Viale
Original Paper

DOI: 10.1007/s10549-006-9429-z

Cite this article as:
Luini, A., Gatti, G., Diaz, J. et al. Breast Cancer Res Treat (2007) 105: 81. doi:10.1007/s10549-006-9429-z

Abstract

Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed.

Keywords

Angiosarcoma of the breast Soft tissue sarcoma Breast surgery 

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Alberto Luini
    • 1
    • 2
  • Giovanna Gatti
    • 1
  • Jack Diaz
    • 1
  • Edoardo Botteri
    • 3
  • Eliegina Oliveira
    • 1
  • Rafaela Cecilio Sahium de Almeida
    • 1
  • Paolo Veronesi
    • 1
    • 2
  • Mattia Intra
    • 1
  • Gianmatteo Pagani
    • 1
  • Paola Naninato
    • 1
  • Giuseppe Viale
    • 4
    • 2
  1. 1.Division of Breast SurgeryEuropean Institute of OncologyMilanItaly
  2. 2.University of Milan, School of MedicineMilanItaly
  3. 3.Division of Epidemiology and BiostatisticsEuropean Institute of OncologyMilanItaly
  4. 4.Division of Pathology European Institute of OncologyMilanItaly

Personalised recommendations